• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Biotechnology in the US Product Image

Biotechnology in the US

  • Published: December 2013
  • Region: North America, United States
  • 54 pages
  • IBISWorld
Blooming efficiency: Healthcare reform and agricultural demands will drive growth

FEATURED COMPANIES

  • Amgen Inc.
  • Genentech Inc.
  • Gilead Sciences Inc.
  • MAJOR COMPANIES.
  • Monsanto Company
  • MORE

Blooming efficiency: Healthcare reform and agricultural demands will drive growth

Biotechnology in the US

Demand for cutting-edge medicines and treatments will result in strong growth for the Biotechnology industry. While it was not entirely immune to the recession, healthcare reform, environmental concerns and the aging population will drive solid revenue growth in the next five years. Furthermore, federal mandates will likely benefit the industry, leading to increases in research and development over the period.

Firms in this industry primarily use living organisms or molecular and cellular techniques to provide chemicals, food and services that meet human needs. The industry excludes companies primarily involved in developing small-molecule pharmaceuticals, performing contract research or manufacturing biological equipment.

This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.

TABLE OF CONTENTS

ABOUT THIS INDUSTRY
Industry Definition
Main Activities
Similar Industries
Additional Resources

INDUSTRY AT A GLANCE

INDUSTRY PERFORMANCE
Executive Summary
Key External Drivers
Current Performance
Industry Outlook
Industry Life Cycle

PRODUCTS & MARKETS
Supply Chain
Products & Services
Demand Determinants
Major Markets
International Trade
Business Locations

COMPETITIVE LANDSCAPE
Market Share Concentration
Key Success Factors
Cost Structure Benchmarks
Basis of Competition
Barriers to Entry
Industry Globalization

MAJOR COMPANIES

OPERATING CONDITIONS
Capital Intensity
Technology & Systems
Revenue Volatility
Regulation & Policy
Industry Assistance

KEY STATISTICS
Industry Data
Annual Change
Key Ratios

JARGON & GLOSSARY

MAJOR COMPANIES.

Monsanto Company

Amgen Inc.

Genentech Inc.

Gilead Sciences Inc.

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos